Table 2 Postoperative outcomes and complications

Short-term (≤ 30 days) complications

0.509

 Complication category

  1. Gastrointestinal

18 (33.3)

11(30.1)

0.31

   Ileus

II

16 (29.6)

10 (27.8)

0.28

   Leakage from uretero-intestinal anastomosis

II

2 (3.7)

1 (2.8)

0.36

  2. Genitourinary

14 (25.9)

10 (27.8)

0.34

   UTI with fever

II

12 (22.2)

8 (22.2)

0.36

   Urosepsis

II

2 (3.7)

2 (5.6)

0.41

  3. Cardiovascular

3 (5.6)

1 (2.8)

0.22

   Atrial fibrillation

II

3 (5.6)

1 (2.8)

0.22

  4. Hematological and vascular

7 (13.0)

5 (13.9)

0.32

   Postoperative ES transfusion

II

2 (3.7)

1 (2.8)

0.36

   Fresh frozen plasma transfusion

II

3 (5.6)

2 (5.6)

0.23

   Deep vein thrombosis

II

2 (3.7)

1 (2.8)

0.36

  5. Pulmonary

4 (7.4)

3 (8.3)

0.35

   Pulmonary infection

4 (7.4)

3 (8.3)

0.35

  6. Wound

7 (13.9)

4 (11.1)

0.43

   Infection

II

2 (3.7)

1 (2.8)

0.36

   Superficial wound dehiscence

II

5 (9.3)

3 (8.3)

0.32

 Intermediate-term (31–90 days) complications

0.192

  1. Gastrointestinal

3 (5.6)

2 (5.6)

0.32

   Constipation

II

3 (5.6)

2 (5.6)

0.32

  2. Genitourinary

5 (9.3)

3 (8.3)

0.13

   Renal function decline

I

2 (3.7)

1 (2.8)

0.36

   UTI with fever

II

2 (3.7)

1 (2.8)

0.36

   Pouch calculi

IIIb

1 (1.9)

1 (2.8)

0.26

   UUT obstruction conservative (mild HUN)

I

2 (3.7)

1 (2.8)

0.36

  3. Miscellaneous

2 (3.7)

1 (2.8)

0.23

   Electrolyte imbalance

I

2 (3.7)

1 (2.8)

0.23

 Urinary function

  Daytime continence

36 (75)

26 (72.5)

0.89

  Nighttime continence

26 (54.1)

20 (55.5)

0.96

 Daytime pads used at 12 months

0.083

  Mean (± SD)

1.1 (± 0.8)

0.7 (± 0.7)

 Nighttime pads used at 12 months

0.099

  Median (IQR)

1 (1.1)

1 (0.1)

 Capacity (mL)

  Mean (± SD)

428.9 (± 25)

417.2 (± 30.6)

0.169

 Post-micturition residual urine at 2 months (mL)

  Mean (± SD)

50.7 (± 18.2)

26.7 (± 11.9)

< 0.001